R. Bjørneklett, B. E. Vikse, E. Svarstad, K. Aasarød, L. Bostad et al., Long-term risk of cancer in membranous nephropathy patients, Am J Kidney Dis, vol.50, pp.396-403, 2007.

J. F. Cambier and P. Ronco, Onco-nephrology: Glomerular diseases with cancer, Clin J Am Soc Nephrol, vol.7, pp.1701-1712, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00919120

C. Lefaucheur, B. Stengel, D. Nochy, P. Martel, G. S. Hill et al., Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association, Kidney Int, vol.70, pp.1510-1517, 2006.

A. S. De-vriese, R. J. Glassock, K. A. Nath, S. Sethi, and F. C. Fervenza, A proposal for a serology-based approach to membranous nephropathy, J Am Soc Nephrol, vol.28, pp.421-430, 2017.

C. Zaghrini, B. Seitz-polski, J. Justino, G. Dolla, C. Payré et al., Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy, Kidney Int, vol.95, pp.666-679, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02380896

J. Wang, Z. Cui, J. Lu, C. Probst, Y. M. Zhang et al., Circulating antibodies against thrombospondin type-I domaincontaining 7A in Chinese patients with idiopathic membranous nephropathy, Clin J Am Soc Nephrol, vol.12, pp.1642-1651, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02193806

E. Hoxha, T. Wiech, P. R. Stahl, G. Zahner, N. M. Tomas et al., A mechanism for cancer-associated membranous nephropathy, N Engl J Med, vol.374, 1995.

S. A. Timmermans, R. Ayalon, P. Van-paassen, L. H. Beck, H. Van-rie et al., Cohen Tervaert JW

, Limburg Renal Registry: Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy, Am J Kidney Dis, vol.62, pp.1223-1225, 2013.

Z. Feng, S. Wang, Y. Huang, X. Liang, W. Shi et al., A follow-up analysis of positron emission tomography/computed tomography in detecting hidden malignancies at the time of diagnosis of membranous nephropathy, Oncotarget, vol.7, pp.9645-9651, 2016.

S. Sheikhbahaei, C. V. Marcus, R. S. Fragomeni, S. P. Rowe, and M. S. Javadi, Solnes LB: Whole-body 18 F-FDG PET and 18 F-FDG PET/CT in patients with suspected paraneoplastic syndrome: A systematic review and Meta-analysis of diagnostic accuracy, J Nucl Med, vol.58, pp.1031-1036, 2017.